Novo Nordisk files for FDA approval of CagriSema (December 18, 2025)
In humans, large proportions of orally administered d-allulose are absorbed and subsequently excreted via the urine without being metabolized 14
The Medicare GLP-1 bridge program is a separate pilot run by CMS with Humana, outside your standard Part D plan, and it has its own eligibility rules and $50 monthly co-payment
CJC-1295 is a molecule that appears to bind to the growth hormone-releasing hormone (GHRH) receptors, which may cause the release of growth hormone by pituitary cells
Against this backdrop of rising obesity and new pharmacologic strategies, it is critical to note that the majority of patients undergoing orthopedic surgery, particularly joint arthroplasty, meet criteria for obesity (BMI 3039.9) or morbid obesity (BMI 40)
Meanwhile, strawberry shortcake nails point to a nostalgiainfused trend